Evidence map›Paper›PMID 24633240›Full record

ArticleNature biotechnology2014

Development and function of human innate immune cells in a humanized mouse model.

Anthony Rongvaux, Tim Willinger, Jan Martinek, Till Strowig, Sofia V Gearty, Lino L Teichmann, Yasuyuki Saito, Florentina Marches, Stephanie Halene, A Karolina Palucka and 2 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 500 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
500citing papers in PubMed, 1 pooled it
25.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

500 citing papers in PubMed, 1 synthesis or guideline pooled it, 748 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. IL-9R/Arg1 pathway promotes polyamine metabolism in human airway macrophages.The Journal of allergy and clinical immunology · 2026
    Article
  8. The making of cells and organs in xenogeneic animal bioreactor.Signal transduction and targeted therapy · 2026
    Review
  9. Article
  10. Review
  11. Humanized immune system animal models and their recent applications.Animal models and experimental medicine · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

440 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Anthony Rongvaux1] Department of Immunobiology, Yale University, New Haven, Connecticut, USA. [2].
Tim Willinger1] Department of Immunobiology, Yale University, New Haven, Connecticut, USA. [2].
Jan Martinek1] Baylor Institute for Immunology Research, Dallas, Texas, USA. [2] Biomedical studies program, Baylor University, Waco, Texas, USA.
Till Strowig1] Department of Immunobiology, Yale University, New Haven, Connecticut, USA. [2].
Sofia V GeartyDepartment of Immunobiology, Yale University, New Haven, Connecticut, USA.
Lino L Teichmann1] Department of Laboratory Medicine, Yale University, New Haven, Connecticut, USA. [2] Department of Medicine III, University Hospital Bonn, Bonn, Germany.
Yasuyuki SaitoDivision of Hematology, University Hospital Zurich, Zurich, Switzerland.
Florentina MarchesBaylor Institute for Immunology Research, Dallas, Texas, USA.
Stephanie HaleneSection of Hematology, Department of Internal Medicine and Yale Comprehensive Cancer Center, Yale University, New Haven, Connecticut, USA.
A Karolina PaluckaBaylor Institute for Immunology Research, Dallas, Texas, USA.
Markus G ManzDivision of Hematology, University Hospital Zurich, Zurich, Switzerland.
Richard A Flavell1] Department of Immunobiology, Yale University, New Haven, Connecticut, USA. [2] Howard Hughes Medical Institute, Yale University, New Haven, Connecticut, USA.
Yale University · USUniversity Hospital of Zurich · CH

Funding

Induction of melanoma immunity by dendritic cell subsetsP01CA084512 · NCI · ROCKEFELLER UNIVERSITY · PI BANCHEREAU, JACQUES F · 2000 to 2010
$12.1M
Understanding Hemotopoietic Neoplasias using Humanized MiceR01CA156689 · NCI · YALE UNIVERSITY · PI DHODAPKAR, MADHAV V, FLAVELL, RICHARD A · 2010 to 2014
$5.0M
Diversification of Cytotoxic Effector Cells Via LPS-activated DCsR01CA129350 · NCI · BAYLOR RESEARCH INSTITUTE · PI PALUCKA, ANNA KAROLINA · 2008 to 2011
$2.2M
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T CellsR01CA140602 · NCI · BAYLOR RESEARCH INSTITUTE · PI PALUCKA, ANNA KAROLINA · 2010 to 2013
$1.4M
Howard Hughes Medical InstituteNCI NIH HHS CA129350NCI NIH HHS CA140602NCI NIH HHS CA156689NCI NIH HHS CA84512NCI NIH HHS P01 CA084512NCI NIH HHS R01 CA129350NCI NIH HHS R01 CA140602NCI NIH HHS R01 CA156689
6 · The paper itself

Abstract

Mice repopulated with human hematopoietic cells are a powerful tool for the study of human hematopoiesis and immune function in vivo. However, existing humanized mouse models cannot support development of human innate immune cells, including myeloid cells and natural killer (NK) cells. Here we describe two mouse strains called MITRG and MISTRG, in which human versions of four genes encoding cytokines important for innate immune cell development are knocked into their respective mouse loci. The human cytokines support the development and function of monocytes, macrophages and NK cells derived from human fetal liver or adult CD34(+) progenitor cells injected into the mice. Human macrophages infiltrated a human tumor xenograft in MITRG and MISTRG mice in a manner resembling that observed in tumors obtained from human patients. This humanized mouse model may be used to model the human immune system in scenarios of health and pathology, and may enable evaluation of therapeutic candidates in an in vivo setting relevant to human physiology.

Indexed as

Killer Cells, NaturalMyeloid CellsAnimalsHumansImmunity, InnateLeukemic InfiltrationMiceMice, TransgenicNeoplasms, ExperimentalTransplantation, Heterologous

Identifiers

PMID24633240
PMCPMC4017589
OpenAlexW2007987850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.